1812 ET - Masimo investors will likely be pleased with the appointment of Katie Szyman as the medical technology company's next CEO, Wells Fargo analysts say in a research note. Szyman is well respected and overall a good fit given her experience in bringing valuable sector specific knowledge, the analysts say. Her established relationships with key stakeholders and credibility within the industry can help to improve Masimo's growth, too, as the company continues to evaluate a potential separation of its consumer business, the analysts add. "We believe that her appointment will help in retaining and attracting key talent as well as rebuilding investor confidence after a couple of tumultuous years at the company." (sabela.ojea@wsj.com; @sabelaojeaguix)
(END) Dow Jones Newswires
January 21, 2025 18:12 ET (23:12 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.